Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Personal Assistant What is This Site Help Center Crisis
Powered By

Top 10 search results for "Yervoy" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Does Immunotherapy for Lung Cancer Work?
... Stage 4BFor stage 4B cancer that has spread to multiple sites in the body, there are a few options for immunotherapy treatment: Tecentriq, Libtayo, or Keytruda alone Opdivo and Yervoy, potentially in combination with chemotherapy Keytruda or Tecentriq, in combination with chemotherapy Advanced Stage Small Cell Lung CancerExtensive stage SCLC cannot ...
Does Immunotherapy for Lung Cancer Work?
... Stage 4BFor stage 4B cancer that has spread to multiple sites in the body, there are a few options for immunotherapy treatment: Tecentriq, Libtayo, or Keytruda alone Opdivo and Yervoy, potentially in combination with chemotherapy Keytruda or Tecentriq, in combination with chemotherapy Advanced Stage Small Cell Lung CancerExtensive stage SCLC cannot ...
COVID-19 Vaccine Boosters and Additional Doses for People With Lung Cancer: Current Guidelines
... Immunotherapy medications for lung cancer include:Opdivo (nivolumab)Libtayo (cemiplimab)Keytruda (pembrolizumab)Tecentriq (atezolizumab)Imfinzi (durvalumab)Yervoy (ipilimumab)Chemotherapies used to treat lung cancer include:CarboplatinCisplatinTaxotere (docetaxel)Taxol (paclitaxel)Gemzar (gemcitabine)Alimta (pemetrexed)Navelbine (vinorelbine)The American ...
Posted 09/24/2021
COVID-19 Vaccine Boosters and Additional Doses for People With Lung Cancer: Current Guidelines
... Immunotherapy medications for lung cancer include:Opdivo (nivolumab)Libtayo (cemiplimab)Keytruda (pembrolizumab)Tecentriq (atezolizumab)Imfinzi (durvalumab)Yervoy (ipilimumab)Chemotherapies used to treat lung cancer include:CarboplatinCisplatinTaxotere (docetaxel)Taxol (paclitaxel)Gemzar (gemcitabine)Alimta (pemetrexed)Navelbine (vinorelbine)The American ...
Posted 09/24/2021
Health Care Inequity, Treatment Advances Among Research Highlights at World Conference on Lung Cancer
... Other researchers found that the targeted therapy drugs nivolumab (sold under the brand name Opdivo) and ipilimumab (sold under the brand name Yervoy) combined with chemotherapy improved the prognosis of people with stage 4 or relapsed NSCLC. ...
Posted 10/22/2021
Health Care Inequity, Treatment Advances Among Research Highlights at World Conference on Lung Cancer
... Other researchers found that the targeted therapy drugs nivolumab (sold under the brand name Opdivo) and ipilimumab (sold under the brand name Yervoy) combined with chemotherapy improved the prognosis of people with stage 4 or relapsed NSCLC. ...
Posted 10/22/2021
Immunotherapy for Lung Cancer: 4 Types and How They Work
... FDA-approved CTLA-4 Inhibitors for lung cancer include: Ipilimumab (Yervoy) in combination with nivolumab and chemotherapy as a first-line treatment for those with advanced NSCLC Tremelimumab-actl (Imjudo) along with durvalumab to treat metastatic NSCLC when cancer cells lack certain mutations 3. ...
Immunotherapy for Lung Cancer: 4 Types and How They Work
... FDA-approved CTLA-4 Inhibitors for lung cancer include: Ipilimumab (Yervoy) in combination with nivolumab and chemotherapy as a first-line treatment for those with advanced NSCLC Tremelimumab-actl (Imjudo) along with durvalumab to treat metastatic NSCLC when cancer cells lack certain mutations 3. ...
NSCLC Targeted Therapy: 8 Facts
... CTLA-4 inhibitors — These include ipilimumab (Yervoy) and tremelimumab (Imjudo). 5. Most Targeted Therapies Are Taken by MouthMost of the targeted therapy drugs currently available are pills that are given orally (by mouth). This may allow you to take targeted therapy at home. The way you take a targeted drug depends on the type of drug. ...
NSCLC Targeted Therapy: 8 Facts
... CTLA-4 inhibitors — These include ipilimumab (Yervoy) and tremelimumab (Imjudo). 5. Most Targeted Therapies Are Taken by MouthMost of the targeted therapy drugs currently available are pills that are given orally (by mouth). This may allow you to take targeted therapy at home. The way you take a targeted drug depends on the type of drug. ...
Metastatic NSCLC: Symptoms and Treatments
... Some checkpoint inhibitors used to treat NSCLC include: Atezolizumab (Tecentriq) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Side effects of immunotherapy include thyroid problems, inflammation of the intestines or lungs, and skin issues.ChemotherapyYour healthcare team may use chemotherapy alone or combined with targeted therapy ...
Metastatic NSCLC: Symptoms and Treatments
... Some checkpoint inhibitors used to treat NSCLC include: Atezolizumab (Tecentriq) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Side effects of immunotherapy include thyroid problems, inflammation of the intestines or lungs, and skin issues.ChemotherapyYour healthcare team may use chemotherapy alone or combined with targeted therapy ...
Biomarkers for Lung Cancer: 12 Things To Know
... Drugs used include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Tremelimumab (Imjudo) A higher PD-L1 level often means a greater chance that immunotherapy will shrink or control the cancer.11. ...
Biomarkers for Lung Cancer: 12 Things To Know
... Drugs used include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Tremelimumab (Imjudo) A higher PD-L1 level often means a greater chance that immunotherapy will shrink or control the cancer.11. ...
NSCLC Treatment Options: First-Line Treatments and Beyond
... Examples include: Ipilimumab (Yervoy) Tremelimumab-actl (Imjudo) Treatment Options When NSCLC Progresses or ReturnsIf you start NSCLC treatment with a first-line treatment option and your disease progresses or comes back, your healthcare team may discuss follow-up with second- or third-line treatment options with you. ...
NSCLC Treatment Options: First-Line Treatments and Beyond
... Examples include: Ipilimumab (Yervoy) Tremelimumab-actl (Imjudo) Treatment Options When NSCLC Progresses or ReturnsIf you start NSCLC treatment with a first-line treatment option and your disease progresses or comes back, your healthcare team may discuss follow-up with second- or third-line treatment options with you. ...
5 Treatment Types for Advanced NSCLC
... These monoclonal antibodies target CTLA-4, a protein that blocks T-cell activity.Checkpoint inhibitors that are used to treat advanced NSCLC include: Atezolizumab (Tecentriq), which targets PD-L1 Cemiplimab (Libtayo), which targets PD-L1 Durvalumab (Imfinzi), which targets PD-L1 Ipilimumab (Yervoy), which targets CTLA-4 Nivolumab (Opdivo), which targets ...
5 Treatment Types for Advanced NSCLC
... These monoclonal antibodies target CTLA-4, a protein that blocks T-cell activity.Checkpoint inhibitors that are used to treat advanced NSCLC include: Atezolizumab (Tecentriq), which targets PD-L1 Cemiplimab (Libtayo), which targets PD-L1 Durvalumab (Imfinzi), which targets PD-L1 Ipilimumab (Yervoy), which targets CTLA-4 Nivolumab (Opdivo), which targets ...
NSCLC: Advances in Diagnosis, Staging, and Metastatic Therapies (VIDEO)
... For NSCLC, the drugs currently available include: Atezolizumab (Tecentriq) — Targets PD-L1 Cemiplimab (Libtayo) — Targets PD-L1 Durvalumab (Imfinzi) — Targets PD-L1 Ipilimumab (Yervoy) — Targets CTLA-4 Nivolumab (Opdivo) — Targets PD-L1 Pembrolizumab (Keytruda) — Targets PD-1 Tremelimumab (Imjudo) — Targets CTLA-4 Researchers are investigating new ...
NSCLC: Advances in Diagnosis, Staging, and Metastatic Therapies (VIDEO)
... For NSCLC, the drugs currently available include: Atezolizumab (Tecentriq) — Targets PD-L1 Cemiplimab (Libtayo) — Targets PD-L1 Durvalumab (Imfinzi) — Targets PD-L1 Ipilimumab (Yervoy) — Targets CTLA-4 Nivolumab (Opdivo) — Targets PD-L1 Pembrolizumab (Keytruda) — Targets PD-1 Tremelimumab (Imjudo) — Targets CTLA-4 Researchers are investigating new ...